Cargando…

Enteral supplementation with glutamine, fiber, and oligosaccharide modulates incretin and glucagon-like peptide-2 secretion

AIMS/INTRODUCTION: A dietary supplementation product enriched with glutamine, dietary fiber and oligosaccharide (GFO) is widely applied for enteral nutrition support in Japan. The aim of the present study was to evaluate the effects of GFO ingestion on secretion of incretins, gastric inhibitory poly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joo, Erina, Muraoka, Atsushi, Hamasaki, Akihiro, Harada, Norio, Yamane, Shunsuke, Kondo, Yaeko, Suzuki, Kazuyo, Nasteska, Daniela, Shibue, Kimitaka, Harada, Takanari, Iwasaki, Kanako, Tsuji, Hidemi, Shide, Kenichiro, Inagaki, Nobuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420562/ https://www.ncbi.nlm.nih.gov/pubmed/25969715 http://dx.doi.org/10.1111/jdi.12289

Ejemplares similares

Effects of glucose and meal ingestion on incretin secretion in Japanese subjects with normal glucose tolerance
por: Yamane, Shunsuke, et al.
Publicado: (2011)

Plasma gastric inhibitory polypeptide and glucagon‐like peptide‐1 levels after glucose loading are associated with different factors in Japanese subjects
por: Harada, Norio, et al.
Publicado: (2010)

Distribution and hormonal characterization of primary murine L cells throughout the gastrointestinal tract
por: Suzuki, Kazuyo, et al.
Publicado: (2017)

GLP‐1 receptor agonist attenuates endoplasmic reticulum stress‐mediated β‐cell damage in Akita mice
por: Yamane, Shunsuke, et al.
Publicado: (2011)

Solid‐phase extraction treatment is required for measurement of active glucagon‐like peptide‐1 by enzyme‐linked immunosorbent assay kit affected by heterophilic antibodies
por: Hasegawa, Tomonori, et al.
Publicado: (2018)

Regulation of glucagon‐like peptide‐1 sensitivity by gut microbiota dysbiosis
por: Yamane, Shunsuke, et al.
Publicado: (2017)

An analysis of intestinal morphology and incretin-producing cells using tissue optical clearing and 3-D imaging
por: Hatoko, Tomonobu, et al.
Publicado: (2022)

Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19
por: Matsuyama, Toshifumi, et al.
Publicado: (2021)

The Effect of White Rice and White Bread as Staple Foods on Gut Microbiota and Host Metabolism
por: Mano, Fumika, et al.
Publicado: (2018)

Mechanisms of fat‐induced gastric inhibitory polypeptide/glucose‐dependent insulinotropic polypeptide secretion from K cells
por: Yamane, Shunsuke, et al.
Publicado: (2016)

Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in ob/ob mice
por: Shimazu-Kuwahara, Satoko, et al.
Publicado: (2017)

Patients’ Perception on the Nutritional Therapy for Diabetic Nephropathy
por: Shide, Kenichiro, et al.
Publicado: (2014)

Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes
por: Capozzi, Megan E, et al.
Publicado: (2018)

The incretin/glucagon system as a target for pharmacotherapy of obesity
por: Del Prato, Stefano, et al.
Publicado: (2021)

Resolution of Visual Field Defect in Macroprolactinoma After Treatment With Cabergoline
por: Shibue, Kimitaka, et al.
Publicado: (2022)

A Case of Lymphocytic Infundibulo-neurohypophysitis Exhibiting Spontaneous Regression
por: Hasebe, Masashi, et al.
Publicado: (2023)

Glucagon-like peptide 1 and dysglycemia: Conflict in incretin science
por: Singh, Awadhesh Kumar
Publicado: (2015)

Successful Treatment of Postprandial Hyperinsulinemic Hypoglycemia After Billroth-II Gastrojejunostomy Using Octreotide
por: Hasebe, Masashi, et al.
Publicado: (2023)

Rapid exacerbation of lymphocytic infundibuloneurohypophysitis
por: Shibue, Kimitaka, et al.
Publicado: (2017)

Carbohydrate intake is associated with time spent in the euglycemic range in patients with type 1 diabetes
por: Ayano-Takahara, Shiho, et al.
Publicado: (2015)

The Links of Ghrelin to Incretins, Insulin, Glucagon, and Leptin After Bariatric Surgery
por: Skuratovskaia, Daria, et al.
Publicado: (2021)

Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes
por: Yabe, Daisuke, et al.
Publicado: (2011)

Free fatty acid receptors, G protein‐coupled receptor 120 and G protein‐coupled receptor 40, are essential for oil‐induced gastric inhibitory polypeptide secretion
por: Sankoda, Akiko, et al.
Publicado: (2019)

Ubc13 haploinsufficiency protects against age-related insulin resistance and high-fat diet-induced obesity
por: Joo, Erina, et al.
Publicado: (2016)

Role of sodium‐glucose transporters in glucose uptake of the intestine and kidney
por: Harada, Norio, et al.
Publicado: (2012)

Role of clock genes in insulin secretion
por: Harada, Norio, et al.
Publicado: (2016)

Regulation of food intake by intestinal hormones in brain
por: Harada, Norio, et al.
Publicado: (2021)

Chronic primary adrenal insufficiency after unilateral adrenonephrectomy: A case report
por: Yoshiji, Satoshi, et al.
Publicado: (2017)

Exploring a Suitable Marker of Glycemic Response to Dulaglutide in Patients with Type 2 Diabetes: A Retrospective Study
por: Yoshiji, Satoshi, et al.
Publicado: (2022)

Year‐long effects of COVID‐19 restrictions on glycemic control and body composition in patients with glucose intolerance in Japan: A single‐center retrospective study
por: Tsukaguchi, Ryo, et al.
Publicado: (2022)

Relevance of Autophagy Induction by Gastrointestinal Hormones: Focus on the Incretin-Based Drug Target and Glucagon
por: Kanasaki, Keizo, et al.
Publicado: (2019)

The Change in Glucagon Following Meal Ingestion Is Associated with Glycemic Control, but Not with Incretin, in People with Diabetes
por: Yoo, Soyeon, et al.
Publicado: (2021)

Analysis of factors influencing postprandial C‐peptide levels in Japanese patients with type 2 diabetes: Comparison with C‐peptide levels after glucagon load
por: Funakoshi, Shogo, et al.
Publicado: (2011)

Glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1: Incretin actions beyond the pancreas
por: Seino, Yutaka, et al.
Publicado: (2013)

Association of glucagon‐like peptide‐1 receptor‐targeted imaging probe with in vivo glucagon‐like peptide‐1 receptor agonist glucose‐lowering effects
por: Murakami, Takaaki, et al.
Publicado: (2020)

Fructose induces glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1 and insulin secretion: Role of adenosine triphosphate-sensitive K(+) channels
por: Seino, Yusuke, et al.
Publicado: (2015)

Glutamate Acts as a Key Signal Linking Glucose Metabolism to Incretin/cAMP Action to Amplify Insulin Secretion
por: Gheni, Ghupurjan, et al.
Publicado: (2014)

Linagliptin Increases Incretin Levels, Lowers Glucagon, and Improves Glycemic Control in Type 2 Diabetes Mellitus
por: Rauch, Thomas, et al.
Publicado: (2012)

Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies
por: Shaefer, Charles F.
Publicado: (2016)

Incretin concept revised: The origin of the insulinotropic function of glucagon‐like peptide‐1 – the gut, the islets or both?
por: Yabe, Daisuke, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pvk5hknqnupsg7ivubsj0g259b